These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8632704)

  • 21. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
    Hjorth SA; Thirstrup K; Schwartz TW
    Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]U69,593 binding in guinea-pig brain: comparison with [3H]ethylketazocine binding at the kappa-opioid sites.
    Tiberi M; Payette P; Mongeau R; Magnan J
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1368-72. PubMed ID: 2853991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of kappa1-opioid receptor binding in human insular cortex.
    Izenwasser S; Staley JK; Cohn S; Mash DC
    Life Sci; 1999; 65(9):857-62. PubMed ID: 10465345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. kappa-Opioid binding sites on a murine lymphoma cell line.
    Bidlack JM; Saripalli LD; Lawrence DM
    Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes.
    Govitrapong P; Sawlom S; Ebadi M
    Brain Res; 2002 Sep; 951(1):23-30. PubMed ID: 12231452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominance of delta-opioid-binding sites in the porcine enteric nervous system.
    Townsend D; Brown DR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):900-9. PubMed ID: 11861796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
    Bhargava HN; Matwyshyn GA; Gudehithlu KP
    Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. kappa-Opioid receptor recognition sites are not modulated by local anaesthetics.
    Fraser GL; Fowler CJ
    Biochem Pharmacol; 1995 Mar; 49(7):883-91. PubMed ID: 7741760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of opioid receptors in the Mongolian gerbil cerebellum.
    Niwa M; Iwai T; Luay AE; Nozaki M; Tsurumi K
    Life Sci; 1994; 55(16):1277-83. PubMed ID: 7934629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord.
    Stevens CW; Lacey CB; Miller KE; Elde RP; Seybold VS
    Brain Res; 1991 May; 550(1):77-85. PubMed ID: 1653636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
    Newman LC; Sands SS; Wallace DR; Stevens CW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
    Lawrence DM; Joseph DB; Bidlack JM
    Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.